Biomarkers of folate status in NHANES: a roundtable summary123456

A roundtable to discuss the measurement of folate status biomarkers in NHANES took place in July 2010. NHANES has measured serum folate since 1974 and red blood cell (RBC) folate since 1978 with the use of several different measurement procedures. Data on serum 5-methyltetrahydrofolate (5MTHF) and folic acid (FA) concentrations in persons aged ≥60 y are available in NHANES 1999–2002. The roundtable reviewed data that showed that folate concentrations from the Bio-Rad Quantaphase II procedure (Bio-Rad Laboratories, Hercules, CA; used in NHANES 1991–1994 and NHANES 1999–2006) were, on average, 29% lower for serum and 45% lower for RBC than were those from the microbiological assay (MA), which was used in NHANES 2007–2010. Roundtable experts agreed that these differences required a data adjustment for time-trend analyses. The roundtable reviewed the possible use of an isotope-dilution liquid chromatography–tandem mass spectrometry (LC-MS/MS) measurement procedure for future NHANES and agreed that the close agreement between the MA and LC-MS/MS results for serum folate supported conversion to the LC-MS/MS procedure. However, for RBC folate, the MA gave 25% higher concentrations than did the LC-MS/MS procedure. The roundtable agreed that the use of the LC-MS/MS procedure to measure RBC folate is premature at this time. The roundtable reviewed the reference materials available or under development at the National Institute of Standards and Technology and recognized the challenges related to, and the scientific need for, these materials. They noted the need for a commutability study for the available reference materials for serum 5MTHF and FA.

[1]  J. Eckfeldt,et al.  Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES , 2011, American Journal of Clinical Nutrition.

[2]  E. Nexo,et al.  Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility12345 , 2011, American Journal of Clinical Nutrition.

[3]  P. Coates,et al.  Overview of a roundtable on NHANES monitoring of biomarkers of folate and vitamin B-12 status: measurement procedure issues123456 , 2011, The American journal of clinical nutrition.

[4]  B. Shane.  Folate status assessment history: implications for measurement of biomarkers in NHANES12345 , 2011, The American journal of clinical nutrition.

[5]  Elizabeth A Yetley,et al.  Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use , 2011, The American journal of clinical nutrition.

[6]  J. Selhub,et al.  Determination of unmetabolized folic acid in human plasma using affinity HPLC12345 , 2011, The American journal of clinical nutrition.

[7]  R. Carmel.  Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II1234 , 2011, The American journal of clinical nutrition.

[8]  L. Curtin,et al.  Biomarkers of vitamin B-12 status in NHANES: a roundtable summary , 2011, The American journal of clinical nutrition.

[9]  K. Dodd,et al.  Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. , 2010, The American journal of clinical nutrition.

[10]  M. McDowell,et al.  Total folate and folic acid intakes from foods and dietary supplements of US children aged 1-13 y. , 2010, The American journal of clinical nutrition.

[11]  I. Rosenberg,et al.  Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. , 2010, The American journal of clinical nutrition.

[12]  C. Pfeiffer,et al.  Folate Analytical Methodology , 2009 .

[13]  L. Bailey,et al.  Folate in Health and Disease , 2009 .

[14]  A. Staines,et al.  Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? , 2009, BMC public health.

[15]  Per Magne Ueland,et al.  Analytical recovery of folate degradation products formed in human serum and plasma at room temperature. , 2009, The Journal of nutrition.

[16]  P. Ueland,et al.  Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum. , 2009, Clinical chemistry.

[17]  J. Mason.  Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. , 2009, Nutrition reviews.

[18]  V. Ganji,et al.  Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. , 2009, The Journal of nutrition.

[19]  P. Jacques,et al.  Circulating folic acid in plasma: relation to folic acid fortification. , 2008, The American journal of clinical nutrition.

[20]  M. McDowell,et al.  Blood folate levels: the latest NHANES results. , 2008, NCHS data brief.

[21]  R. Jain,et al.  Influence of 5,10-methylenetetrahydrofolate reductase polymorphism on whole-blood folate concentrations measured by LC-MS/MS, microbiologic assay, and bio-rad radioassay. , 2008, Clinical chemistry.

[22]  H. McNulty,et al.  Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. , 2007, The American journal of clinical nutrition.

[23]  P. Verhoef,et al.  Folic acid fortification: is masking of vitamin B-12 deficiency what we should really worry about? , 2007, The American journal of clinical nutrition.

[24]  R. Jain,et al.  Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. , 2007, The American journal of clinical nutrition.

[25]  C. Pfeiffer,et al.  Comparison of serum folate species analyzed by LC-MS/MS with total folate measured by microbiologic assay and Bio-Rad radioassay. , 2007, Clinical chemistry.

[26]  J. Scott,et al.  Folic acid fortification and public health: Report on threshold doses above which unmetabolised folic acid appear in serum , 2007, BMC public health.

[27]  A. Heath,et al.  International Standard for serum vitamin B12 and serum folate: international collaborative study to evaluate a batch of lyophilised serum for B12 and folate content , 2007, Clinical chemistry and laboratory medicine.

[28]  M. Welch,et al.  Development of a new standard reference material: SRM 1955 (homocysteine and folate in human serum) , 2006, Analytical and bioanalytical chemistry.

[29]  R. Jain,et al.  Erythrocyte folate extraction and quantitative determination by liquid chromatography-tandem mass spectrometry: comparison of results with microbiologic assay. , 2005, Clinical chemistry.

[30]  Joshua W. Miller,et al.  Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population , 2005, Clinical chemistry and laboratory medicine.

[31]  M. Welch,et al.  Simultaneous quantification of homocysteine and folate in human serum or plasma using liquid chromatography/tandem mass spectrometry. , 2005, Analytical chemistry.

[32]  C. Pfeiffer,et al.  Measurement of folates in serum and conventionally prepared whole blood lysates: application of an automated 96-well plate isotope-dilution tandem mass spectrometry method. , 2004, Clinical chemistry.

[33]  J. I. Rader,et al.  Modeling the level of fortification and post-fortification assessments: U.S. experience. , 2004, Nutrition reviews.

[34]  Bryant C Nelson,et al.  Solid-phase extraction-electrospray ionization mass spectrometry for the quantification of folate in human plasma or serum. , 2004, Analytical biochemistry.

[35]  E. Gunter,et al.  Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. , 2004, Clinical chemistry.

[36]  A. Heath,et al.  An International Standard for whole blood folate: evaluation of a lyophilised haemolysate in an international collaborative study , 2004, Clinical chemistry and laboratory medicine.

[37]  B. Nelson,et al.  Affinity extraction combined with stable isotope dilution LC/MS for the determination of 5-methyltetrahydrofolate in human plasma. , 2003, Analytical biochemistry.

[38]  J. Selhub,et al.  Analysis of folate form distribution by affinity followed by reversed- phase chromatography with electrical detection. , 2000, Clinical chemistry.

[39]  C. Azen,et al.  Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. , 1999, The American journal of clinical nutrition.

[40]  J. Selhub,et al.  A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Mills,et al.  Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. , 1998, Clinical chemistry.

[42]  E. Gunter,et al.  Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 , 1996 .

[43]  D. Raiten,et al.  Assessment of folate methodology used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). , 1995, The Journal of nutrition.

[44]  F. R. Senti,et al.  Analysis of zinc data from the second National Health and Nutrition Examination Survey (NHANES II). , 1985, The Journal of nutrition.

[45]  F. R. Senti,et al.  Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II). , 1985, The Journal of nutrition.